CancerConnect Launches Online Communities for Patients Diagnosed with Myeloproliferative Neoplasms, Waldenström’s Macroglobulinemia and T Cell Lymphomas

October 28, 2013
For Immediate Release

Contact:
Charles H. Weaver, MD
chweaver@omnihealthmedia.com

CancerConnect Launches Online Communities for Patients Diagnosed with Myeloproliferative Neoplasms, Waldenström’s Macroglobulinemia and T Cell Lymphomas

Sun Valley ID & Fort Worth TX– OMNI Health Media (OMNI) announces the launch of several new online communities for individuals affected by myeloproliferative neoplasms (including  polycythemia vera, essential thrombocythemia, and myelofibrosis), Waldenström’s Macroglobulinemia and T Cell lymphomas. These communities will provide patients and their loved ones with welcome information and support.

OMNI founder and CEO Charles Weaver, MD says, "Our decision to launch these communities reflects our commitment to providing people who have been diagnosed with rare or less common cancers a place to connect. Everyone facing a cancer diagnosis should have access to a trusted resource to learn more about their condition and find support from others facing a similar diagnosis. These communities will be available on www.CancerConnect.com and Seattle Cancer Care Alliance CancerConnect, Dana-Farber CancerConnect, Roswell Park CancerConnect, Loyola CancerConnect, and The James CancerConnect.

Research increasingly shows that cancer patients seek validation, information, and support via social media. Unlike other social media platforms, CancerConnect allows individuals to interact in a HIPPA-compliant, confidential, safe, and secure environment. As part of this program, members of the community can also participate in more than sixty disease-specific national communities for individuals with similar interests. Cancer-specific groups are available, as are groups focused on caregiving, health and wellness, clinical trials, insurance, nutrition and survivorship, providing support for anyone affected by a diagnosis of cancer. Together, these communities offer an online destination populated with rich content to support the many ongoing needs of individuals battling cancer.

About CancerConnect
CancerConnect.com is a comprehensive online resource center for cancer patients and their caregivers. Since 1996, it has been providing best in class, disease-specific patient information, covering relevant topics such as latest treatments, management of side effects, clinical trials, and support groups. Integrated with the CancerConnect resource center is CancerConnect Community, a secure, nationwide social network that allows members to share their experiences and knowledge with people of similar interests. Our goal is to provide a unique refuge of learning and connection amidst what can be the difficult experience of a cancer diagnosis.

About OMNI Health Media
OMNI Health Media (OMNI) is a leading multi-media publisher of health-related information produced specifically for consumers. Each month, OMNI’s content, which focuses on women’s health and wellness, cancer, and rheumatoid arthritis, reaches over 1.5 million people through its print and digital platforms. Topical programming is delivered to large cancer centers such as The University of Kansas, Dana-Farber Cancer Institute, Seattle Cancer Care Alliance, and Memorial Sloan-Kettering Cancer Center, as well as to over 2700 physicians’ practices. In print, OMNI publishes Women, an award-winning quarterly magazine devoted to covering health and wellness issues important to women. OMNI’s digital platforms include awomanshealth.com, the companion website for Women; theRAconnection.com, a site devoted to rheumatoid arthritis and its treatments; and cancerconnect.com, an oncology information resource center and social network portal for cancer patients and their caregivers. OMNI also produces the "Understanding Cancer" video series, featuring "Web Chats with the Experts", and television programming on Lifetime’s "The Balancing Act." OMNI Health Media was established in 1996 and has offices in Sun Valley, Idaho, and Dallas/FortWorth, Texas.